Welcome to Progress in Neurology and Psychiatry’s dedicated website. Progress is for health professionals in secondary and primary care looking after patients with neurological and psychiatric diseases. If you are a health professional working in the field of neurology or psychiatry you can register with us for free access to our content.Sign up for e-alerts and print copies

Latest News

Mental health apps more popular

People are looking for apps that could support their mental health, according to market analysts onefourzero and GK (https://onefourzerogroup.com). Their...Read more

Progress on migraine treatments

Allergan has reported that its calcitonin gene receptor peptide (CGRP) antagonist atogepant met the primary endpoint in a Phase IIb/III efficacy trial for...Read more

Nurturing family reduces mental health risk

A child whose mother has a mental illness but has been part of a nurturing family environment, pre and post pregnancy, is less likely to suffer from a mental...Read more

More effective MS treatments increase productivity

Disease-modifying therapies (DMTs) for multiple sclerosis (MS) that are most effective are more likely to increase work attendance, work carried out and...Read more

Cannabis effective in childhood epilepsy, review finds

After the recent controversy surrounding the Home Office’s confiscation and subsequent return of medicinal cannabis used to treat a child’s epilepsy...Read more

Featured Articles

Primary hyperparathyroidism and neuropsychiatric symptoms
The psychiatric and metabolic symptoms associated with hyperparathyroidism are complex and the correlation between symptom severity and degree of hypercalcaemia is poor. Here, the authors explore such a case of hypercalcaemia and primary hyperparathyroidism which required psychotropic medication and a plan for surgical treatment in the longer term.
Click here to view

Confusion-inducing drugs in a memory assessment service: an audit
A commonly encountered problem within memory services is the identification of medications that cause cognitive side-effects. Here, the authors report on the findings of a clinical audit used to evaluate practice of medical staff against National Institute for Health and Care Excellence (NICE) guidance on the ‘assessment and diagnosis of dementia’. 
Click here to view

Functional cognitive disorders: memory clinic study
‘Functional cognitive disorders’ (FCD) is a terminology suggested to denote patients who present with memory complaints but in whom no underlying cognitive disorder is found. Rather than a diagnosis of exclusion, FCD may be positively identified on the basis of typical symptom profiles. Dr Bharambe and Dr Larner examine their data from a dedicated memory clinic, in which historically >50% of patients have not received a diagnosis of either dementia or mild cognitive impairment.
Click here to view

Web design and marketing agency Leamington Spa